Poša M |
Heuman indices of hydrophobicity of bile acids and their comparison with a newly developed and conventional molecular descriptors. |
2014 |
Biochimie |
pmid:24076126
|
Balmer ML et al. |
Effects of ursodeoxycholic acid in combination with vitamin E on adipokines and apoptosis in patients with nonalcoholic steatohepatitis. |
2009 |
Liver Int. |
pmid:19422479
|
Cuesta de Juan S et al. |
Ontogenic development-associated changes in the expression of genes involved in rat bile acid homeostasis. |
2007 |
J. Lipid Res. |
pmid:17332599
|
Chon CY and Park JY |
[Primary biliary cirrhosis]. |
2006 |
Korean J Hepatol |
pmid:16998288
|
Li H et al. |
FXR-activating ligands inhibit rabbit ASBT expression via FXR-SHP-FTF cascade. |
2005 |
Am. J. Physiol. Gastrointest. Liver Physiol. |
pmid:15591588
|
Harmand PO et al. |
Ursolic acid induces apoptosis through mitochondrial intrinsic pathway and caspase-3 activation in M4Beu melanoma cells. |
2005 |
Int. J. Cancer |
pmid:15523687
|
Batta AK et al. |
Hydrophilic 7 beta-hydroxy bile acids, lovastatin, and cholestyramine are ineffective in the treatment of cerebrotendinous xanthomatosis. |
2004 |
Metab. Clin. Exp. |
pmid:15131757
|
Xu G et al. |
Regulation of the farnesoid X receptor (FXR) by bile acid flux in rabbits. |
2002 |
J. Biol. Chem. |
pmid:12401785
|
Nakashima T et al. |
Differences in the efficacy of ursodeoxycholic acid and bile acid metabolism between viral liver diseases and primary biliary cirrhosis. |
2001 |
J. Gastroenterol. Hepatol. |
pmid:11350551
|
Nakashima T et al. |
A paucity of unusual trihydroxy bile acids in the urine of patients with severe liver diseases. |
1999 |
Hepatology |
pmid:10216137
|